Current role
Bill Ringo
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bill Ringo
Faeth Therapeutics, Inc. reported in an 8-K filed February 8, 2024 that Bill Ringo was appointed Interim Chair of the Nominating and Corporate Governance Committee, effective February 6, 2024.
“On February 6, 2024, the Board approved a reduction in the number of directors on the Board from nine to eight and appointed Bill Ringo as Interim Chair of the Nominating and Corporate Governance Committee, each effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Faeth Therapeutics, Inc. (FTH)
SEC 8-K
Current2024-02-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Faeth Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Anand Parikh CEO, Chairman, COO, Board Member
- John Celebi CEO, Board Member
- William Ringo Chairman, Board Member
- Brian Stephenson CFO
- Josiah Craver CFO, Chief Accounting Officer
- Christopher W. Gerry General Counsel, Board Member
- Bob Holmen Board Member
- Karen Vousden, Ph.D. Board Member
- Kristian Humer Board Member
- Phillip B. Donenberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.